Tesla sold 8,621 cars in China in July, accounting for just 3.9 percent sales of battery electric vehicles in the country, down nearly 70 percent from its 12.6 percent share in June, according to the China Passenger Car Association.
Analyst Gordon Johnson said that Tesla overbuilt Chinese capacity when compared to domestic demand, which will result in further price cuts and margin pressure.
But Tesla investors seemed unfazed by the sales decline, with shares dropping less than 2 percent in early trading Tuesday.
Last month, Tesla exhibited that its declining numbers in China didn't stop it from posting better than expected global sales for the full quarter, according to Wedbush Securities tech analyst Dan Ives. He noted that its numbers in China had not been the best indicator of Tesla's success.
Nonetheless, Ives warned that if Tesla's sales in China don't improve, it could eventually face serious problems.
Meanwhile, the export of Tesla cars built at its Shanghai plant soared to 24,347 for July, compared with 5,017 in June.


Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10%
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core
Netflix Stock Slips After Earnings as Soft 2026 Guidance Overshadows Subscriber Milestone
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York
U.S. Dollar Slides Toward Biggest Annual Loss Since 2017 as 2026 Risks Loom
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand
South Korea Factory Output Misses Forecasts in November Amid Ongoing Economic Uncertainty
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales
Japanese Business Leaders Urge Government Action as Weak Yen Strains Economy
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer
U.S. Dollar Starts 2026 Weak as Yen, Euro and Sterling Hold Firm Amid Rate Cut Expectations 



